GNH India Pharmaceuticals Limited, incorporated in 2018 and headquartered in Mumbai, is engaged in the global supply of orphan drugs and specialty pharmaceutical products catering to rare disease treatments and critical healthcare requirements.
The Company provides services including named patient supply, clinical trial supply, reference listed drugs, and validated cold chain logistics, supported by a global sourcing network and compliance with WHO-GSDP and international quality standards.
With operations spanning domestic and international markets, the Company focuses on ensuring timely access to critical medicines, supported by regulatory compliance, supply chain capabilities, and established relationships with global suppliers and distributors.